Relationship between heart failure treatment and development of worsening renal function among hospitalized patients.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Heart Journal

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AHJ.2003.08.012PMID 14760333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

  2002cited by this paper
• Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study.

  2002cited by this paper
• The prognostic importance of different definitions of worsening renal function in congestive heart failure.

  2002cited by this paper
• Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.

  2001cited by this paper
• The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

  2001cited by this paper
• The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

  2000cited by this paper
• The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

  2000cited by this paper
• Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

  2000cited by this paper
• Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure.

  2000cited by this paper
• Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

  2000cited by this paper
• Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure.

  1999cited by this paper
• Clinical outcomes in heart failure: report from a community hospital-based registry.

  1999cited by this paper
• Diuretic therapy.

  1998cited by this paper
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

  1997cited by this paper
• Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

  1996cited by this paper
• Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

  1996cited by this paper
• Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure

  1995cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• Furosemide in patients with heart failure: Shift in dose‐response curves

  1980cited by this paper
• Pharmacokinetics of furosemide in patients with congestive heart failure.

  1979cited by this paper

• The right heart perspective in chronic cardiorenal syndrome: the key role of right heart function and tricuspid regurgitation innovation

  2026cites this paper
• Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium.

  2026cites this paper
• An Analysis of Initial Loop Diuretic Dosing Strategies and Its Association with Time to Decongestion

  2025cites this paper
• Protocolized natriuresis-guided diuretic therapy in acute heart failure: a systematic review and meta-analysis

  2025cites this paper
• Optimisation of heart failure management: insights into GDMT and loop diuretic utilisation in a specialised heart failure clinic

  2025cites this paper
• Home‐based urinary sodium monitoring via point‐of‐care testing for personalized diuretic titration in heart failure management: The EASY‐STOP study

  2025cites this paper
• Management of Decongestion in Acute Heart Failure: Time for a New Approach?

  2025cites this paper
• Comparative efficacy of different drugs in acute heart failure with renal dysfunction: a systematic review and network meta-analysis

  2025cites this paper
• Evaluation of Serum level of Sodium and Potassium in Patients with Congestive Heart Failure

  2024cites this paper
• Renal Biomarkers in Heart Failure

  2024cites this paper
• The Effect of Tolvaptan on Metabolism and Electrolyte Homeostasis in Patients with Heart Failure: A Systematic Review and Meta-Analysis

  2024cites this paper
• Kardiorenales Syndrom bei geriatrischen Patienten

  2024cites this paper
• Estimated Long-Term Benefits of Finerenone in Heart Failure

  2024cites this paper
• Syndromes cardiorénaux de type 1 et de type 2

  2024cites this paper
• Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions – Part I: Loop Diuretics

  2024cites this paper
• Acute kidney injury and its associated factors among patients with acute decompensated heart failure admitted to the university of Gondar Hospital, Northwest Ethiopia: a hospital-based cross-sectional study

  2024cites this paper
• Kardiorenales Syndrom bei geriatrischen Patienten

  2024cites this paper
• Cardiorenal Syndrome: Challenges in Everyday Clinical Practice and Key Points towards a Better Management

  2023cites this paper
• Calcium channel blockers and clinical outcomes in patients with continuous‐flow left ventricular assist devices

  2023cites this paper
• Predictive Health: Chronic Kidney Disease Case Study

  2023cites this paper
• Efficacy and safety of early ultrafiltration in patients with acute decompensated heart failure: a meta-analysis

  2023cites this paper
• Evaluation of sodium‐glucose cotransporter 2 inhibitors for renal prognosis and mortality in diabetes patients with heart failure on diuretics

  2023cites this paper
• Comparison between Torsemide Infusion Versus Intermittent Boluses and Their Impact-On Thoracic Fluid Content in Acute Decompensated Heart Failure Critically Ill Patients

  2023cites this paper
• Association between changes in loop diuretic dose and outcomes in acute heart failure

  2023cites this paper
• Worsening renal function in hospitalized patients with systolic heart failure: prevalence and risk factors

  2023cites this paper
• Prognostic role of renal replacement therapy among hospitalized patients with heart failure in the Brazilian national public health system

  2023cites this paper
• The Prognostic Impact of Renal Function Decline during Hospitalization for Heart Failure

  2023cites this paper
• Timing of Worsening Renal Function in Patients Hospitalized for Heart Failure Exacerbation Who Were Being Treated With Intravenous Diuretic Therapy.

  2023cites this paper
• How should we treat acute kidney injury caused by renal congestion?

  2023cites this paper
• Comparison of Different Furosemide Regimens in the Treatment of Acute Heart Failure: A Meta-Analysis

  2022cites this paper
• The Impact of Cardio Renal Syndrome (CRS) in Renal Transplant Recipients: A Systematic Review

  2022cites this paper
• Effects of mokuboito, a Japanese Kampo medicine, on long‐term clinical outcomes in patients with heart failure

  2022cites this paper
• Frontier and Hotspot Evolution in Cardiorenal Syndrome: a Bibliometric analysis from 2003 to 2022.

  2022cites this paper
• Clinical Effects of Early and Short-Term Tolvaptan Administration in Patients Hospitalized for Acute Decompensated Heart Failure

  2021cites this paper
• A Study on Continuous Infusion versus Intermittent bolus dosing of Furosemide in Hospitalized Heart failure patients

  2021cites this paper
• A protocol for systematic review and meta-analysis

  2021cites this paper
• Uso da Terapia Diurética em Pacientes com Insuficiência Cardíaca Descompensada e Lesão Renal Aguda. O Que Fazer nesse Dilema?

  2021cites this paper
• Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction

  2021cites this paper
• Possible Option for Treatment of Severe Congestive Heart Failure Under Mechanical Ventilation Using Tolvaptan via Nasogastric Tube: A Single-Center Analysis

  2021cites this paper
• The pathophysiology and management of diuretic resistance in patients with heart failure

  2021cites this paper
• High Dose Loop-Diuretic Treatment Results in Higher Mortality Rate in Elderly Heart Failure Patients (>80 years) versus Standardized Neuroendocrine Treatment

  2020cites this paper
• Transfusion-associated circulatory overload in gastroenterology.

  2020cites this paper
• The impact of the first 24 h of loop diuretic on kidney function in acute decompensated heart failure

  2020cites this paper
• Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction

  2020cites this paper
• Apixaban Level and Its Influence on Immunosuppression and Graft Outcome in Kidney Transplant Recipients With Atrial Fibrillation

  2020cites this paper
• Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) Trial

  2020cites this paper
• Treatment of Acute Decompensated Heart Failure: Systematic Literature Review

  2020cites this paper
• Pharmacological and Non-pharmacological Strategies for Volume Overload in Acute Decompensated Congestive Heart Failure: A Review Article

  2020cites this paper
• Tolvaptan add‐on therapy in patients with acute heart failure: A systematic review and meta‐analysis

  2020cites this paper
• Risk Factors for AKI Development in Acute Decompensated Heart Failure

  2020cites this paper
• Increased mortality in elderly heart failure patients receiving infusion of furosemide compared to elderly heart failure patients receiving bolus injection

  2020cites this paper
• Advent of New perioperative care for fluid management after cardiovascular surgery: A review of current evidence.

  2020cites this paper
• CARDIORENAL SYNDROME: THE REVIEW OF CURRENT UNDERSTANDING

  2020cites this paper
• Diuretic and renal effects of spironolactone and heart failure hospitalizations: a TOPCAT Americas analysis

  2020cites this paper
• Associations of worsening renal function with loop diuretics in patients with heart failure with different ejection fraction categories

  2020cites this paper
• Immediate effects of whole blood donation on the endothelial surface layer and glycocalyx shedding.

  2020cites this paper
• Which is the best strategy for using diuretics in decompensated chronic heart failure?

  2019cites this paper
• Flash Pulmonary Edema: Staying Afloat in the Flash Flood

  2019cites this paper
• Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function.

  2019cites this paper
• Loop Diuretics-Analysis of Efficacy Data for the Perioperative Clinician.

  2019cites this paper
• Interactive and potentially independent roles of renin–angiotensin–aldosterone system blockade and the development of cardiorenal syndrome type 1 on in-hospital mortality among elderly patients admitted with acute decompensated congestive heart failure

  2019cites this paper
• Acute Heart Failure and Pulmonary Edema

  2019cites this paper
• Evaluating the adherence to guidelines for management of acute heart failure in the Gaza Strip hospitals: A medical chart–based review study

  2019cites this paper
• Prognostic Impact of Worsening Renal Function in Hospitalized Heart Failure Patients With Preserved Ejection Fraction: A Report From the JASPER Registry.

  2019cites this paper
• Insights on Diuretic Therapy from Clinical and Pharmacologic Perspectives

  2019cites this paper
• Trajectories of Renal Function During Heart Failure Hospitalization: Beware the Bumpy Ride!

  2019cites this paper
• Cardiorenal Syndrome Type 1

  2019cites this paper
• Hemodynamic Insights to Cardio-Renal Syndrome: A View Looking Back to See Forward

  2019cites this paper
• Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.

  2019cites this paper
• Use of Tolvaptan 15 mg in Heart Failure Patients to Improve Sodium Level (Serum & Urinary) and Urinary Osmolality

  2019cites this paper
• Management of Acute Hypertensive Heart Failure.

  2019cites this paper
• miR-21-5p regulates mitochondrial respiration and lipid content in H9C2 cells.

  2019cites this paper
• WORSENING RENAL FUNCTION IN ACUTE DECOMPENSATED HEART FAILURE: A BAD SIGN, OR MAYBE NOT?

  2019cites this paper
• Clinical impact of visceral-to-subcutaneous fat ratio in patients with acute aortic dissection

  2019cites this paper
• Association between loop diuretic dose administered in first 24 hours of heart failure admissions and length of hospital stay

  2018cites this paper
• Epidemiology of Cardiorenal Syndrome.

  2018cites this paper
• Renal congestion related to worsening renal function in patients with acute decompensated heart failure: Diuretic strategy for acute cardiorenal syndrome

  2018cites this paper
• Tratamiento congestivo: diuréticos, resistencia diurética y alternativas Papel de la ultrafiltración

  2018cites this paper
• Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics.

  2018cites this paper
• Impact of Continuous Administration of Tolvaptan on Preventing Medium-Term Worsening Renal Function and Long-Term Adverse Events in Heart Failure Patients with Chronic Kidney Disease.

  2018cites this paper
• Echocardiographic predictors of change in renal function with intravenous diuresis for decompensated heart failure

  2018influential citation
• The pathophysiology of chronic cardiorenal disease based on central hemodynamics

  2018cites this paper
• Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide

  2018cites this paper
• Predictors of clinical outcome in heart failure patients treated with vasopressin type 2 receptor antagonist

  2018cites this paper
• Reversal of the Norm: Pressure Discrepancies on the Two Sides of the Septum in Chronic Kidney Disease Patients with Congestive Heart Failure

  2018cites this paper
• Tolvaptan for Heart Failure in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.

  2018cites this paper
• Cardiac Intensive Care

  2018influential citation
• Running on the Empty: hemodialysis patients with fluid overload, low blood pressure, and intractable congestive heart failure

  2018cites this paper
• The dark side of the kidney in cardio-renal syndrome: renal venous hypertension and congestive kidney failure

  2018influential citation
• Tolvaptan for heart failure with volume overload not responding to conventional treatment: A retrospective analysis

  2018cites this paper
• Retrospective analysis of clinical and analytical patterns of cardiorenal syndrome in a series of 58 patients admitted to a level 2 intermediate care unit

  2018cites this paper
• The dark side of the kidney in cardio-renal syndrome: renal venous hypertension and congestive kidney failure

  2018cites this paper
• Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content

  2017cites this paper
• Tolvaptan, Is It a Trump to Worsening Renal Function?

  2017cites this paper
• The top tertile of hematocrit change during hospitalization is associated with lower risk of mortality in acute heart failure patients

  2017influential citation
• Effects of Tolvaptan With or Without the Pre-Administration of Renin-Angiotensin System Blockers in Hospitalized Patients With Acute Decompensated Heart Failure.

  2017cites this paper
• Prevalence and Predictor of Cardio Renal Syndrome in Dilated Cardiomyopathy

  2017cites this paper
• Serum Albumin level can predict Cardiorenal Syndrome type -1

  2017cites this paper
• Progression and outcomes of non‐dialysis dependent chronic kidney disease patients: A single center longitudinal follow‐up study

  2017cites this paper
• Cardiorenal Syndrome, Hemodynamics, and Noninvasive Evaluation:

  2017cites this paper